Sign on to your service
---------------------------------
LexisNexis at lexis.com
Nexis
LexisNexis by Credit Card
---------------------------------
Academic
Accurint
Analyzer
Anti-Money Laundering Solutions
atVantage
Automated Forms
Collection Solutions
Congressional
Corporate Legal
CourtLink
CourtLink Strategic Profiles
Daily Opinion Service
Development Pro
Environmental
Europe Web Product
Experts & Services Directory
Express Screening
File & Serve
Full Service Screening
Get & Print
Gov Periodicals Index
InstantID
InstantID Q&A
Insurance Compliance
Insurance Solutions
Intranet Solutions
Law Schools
Law Enforcement Solutions
lexisONE
MarketImpact
Martindale-Hubbell
Matthew Bender Online
Mealey's Free Legal News
Mealey's Online
PowerInvoice
Primary Sources in U.S. History
Professional Development Center
Publisher
Purch. & Supply Chain Solutions
Risk Management Solutions
RiskWise
Scholastic Edition
State Capital
Statistical
Tax Center
Telnet Connection
Total Litigator
Vendor Screening
Litigation Services
>
Legal News
>
News Story
Buy Now
Contact A Sales Rep
Access to
Total Litigator
Home
Early Case
Assessment
Draft,
File and Serve
Discovery
Research
Gather
Intelligence
Trial Prep
Alerts and
Tracks
Search by
Source
ViewLitigation Headlines
Legal News & Litigation Reports
Legal News
Headlines
View by Topic
View by Jurisdiction
Verdicts & Settlements
Free Views
Commentaries
Litigation Reports
View by Topic
View by Jurisdiction
Executive Summaries
What's New
Document Access Services
Contact
RSS News Feeds
Podcasts
Email This Page
Print This Page
Legal News
Federal Practice
Wednesday, December 02, 2009
Stryker Biotech, 4 Execs Indicted For Off-Label Sales Of Bone Repair Products
BOSTON - Stryker Biotech LLC and four current or former executives were indicted Oct. 28 on federal criminal charges of conspiracy, making false statements, wire fraud and misbranding in connection with off-label promotion of two of its bone repair products (United States of America v. Stryker Biotech, LLC, et al., No. n/a, D. Mass.).
From Mealey's Emerging Drugs & Devices
Access this news story on Lexis.com
Buy the full report in print
Buy this news story on MealeysOnline
Related Court Documents on MealeysOnline:
Indictment. Document #28-091119-001F.
View Headlines by Topic
Alternative Dispute Resolution
Attorney's Fees
Banking Law
Bankruptcy
Business Law
Civil Practice & Procedure: Federal
Civil Practice & Procedure: State
Commercial Law
Constitutional Law
Contracts
Copyright
Criminal Justice
Criminal Law & Procedure
Employment/Labor Law
Evidence
General Practice
Government Law
Health Care Law
Insurance Law
Intellectual Property Law
International
Legal Method and Process
Litigation
Motor Vehicle/Traffic Law
Patent Law
Personal Injury Law/Medico-Legal
Products Liability
Regulatory Law
Remedies
Securities Law
Statutes
Torts
Trademarks
View Headlines by Jurisdiction
Select a Jurisdiction
California
Colorado
Delaware
District of Columbia
FEDERAL
Florida
Georgia
International
Kentucky
Louisiana
Michigan
Minnesota
Mississippi
Missouri
New Jersey
New York
North Carolina
Pennsylvania
Tennessee
Texas
Virginia
Washington
BREAKING NEWS
Zyprexa MDL Judge Hands Mississippi 1st Setback In States' Medicaid Litigation
Supreme Court Justices Question Merck's Vioxx Defense
Ford Fails In Bid To Supreme Court, $82.6M Award In Accident Case Stands
>
View all Breaking News
Related Products
Federal Practice Litigation Reports
LexisNexis Real Estate Report
Mealey's Litigation Report: Benzene
View more Federal Practice Litigation Reports
Buy Now
Contact A Sales Rep